|
ZNF643 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.77110000000003E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.579480E-04 |
| Normal-vs-Stage2 |
6.604600E-03 |
| Normal-vs-Stage3 |
4.152600E-04 |
| Normal-vs-Stage4 |
1.219200E-03 |
| Stage1-vs-Stage2 |
7.694200E-01 |
| Stage1-vs-Stage3 |
6.324000E-01 |
| Stage1-vs-Stage4 |
7.040600E-01 |
| Stage2-vs-Stage3 |
9.942200E-01 |
| Stage2-vs-Stage4 |
9.930400E-01 |
| Stage3-vs-Stage4 |
9.976200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.96419999999709E-05 |
| Normal-vs-AfricanAmerican |
1.793400E-01 |
| Normal-vs-Asian |
5.475900E-02 |
| Caucasian-vs-AfricanAmerican |
4.618500E-03 |
| Caucasian-vs-Asian |
7.912200E-01 |
| AfricanAmerican-vs-Asian |
1.378810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.21999999999722E-05 |
| Normal-vs-Female |
2.990600E-04 |
| Male-vs-Female |
5.027200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.005840E-02 |
| Normal-vs-Age(41-60Yrs) |
5.67000000000206E-05 |
| Normal-vs-Age(61-80Yrs) |
1.169910E-04 |
| Normal-vs-Age(81-100Yrs) |
2.831200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.350800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.236200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.855150E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.834200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.847800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.464300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.268630E-01 |
| Normal-vs-Grade 2 |
3.66880000000069E-05 |
| Normal-vs-Grade 3 |
2.219800E-04 |
| Normal-vs-Grade 4 |
7.231400E-04 |
| Grade 1-vs-Grade 2 |
6.289600E-01 |
| Grade 1-vs-Grade 3 |
7.814400E-01 |
| Grade 1-vs-Grade 4 |
5.792800E-01 |
| Grade 2-vs-Grade 3 |
4.490600E-01 |
| Grade 2-vs-Grade 4 |
8.051400E-01 |
| Grade 3-vs-Grade 4 |
4.560200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.16450000000746E-05 |
| Normal-vs-ccB subtype |
1.64543999999767E-05 |
| ccA subtype-vs-ccB subtype |
5.654400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.80221999999119E-05 |
| Normal-vs-N1 |
3.149700E-02 |
| N0-vs-N1 |
9.830800E-01 |
|
|
